igf-1 lr3 subq or im Recombinant Human IGF-I/IGF-1 GMP Protein, CF 8335D-GMP: R&D Systems Insulin-Like Growth Factor-1 (IGF-1) and

A 1-year randomized placebo-controlled clinical trial of erdosteine in 445 with GOLD stage II/III COPD (the RESTORE study), revealed a 19.4% decrease in the number of respiratory exacerbations in the group on active drug, and no increase in adverse events was reported

Derksen TM, Bours MJ, Mols F, Weijenberg MP

Recommended Best Injection Method] Items you will need 1

Nigamatzyanova, L

Technical parameters and documentation standards Manufactured under Current Good Manufacturing Practice regulations Adheres to documented USP criteria for laboratory-grade water Individual batches verified for endotoxin and sterility markers Certificate of Analysis available for laboratory audit trails Maintaining research compound stability and efficacy Unpunctured vials should be maintained at controlled room temperature